Antiproliferative and proapoptotic effects of somatostatin on activated hepatic stellate cells

Table 1 Effects of somatostatin on HSC proliferation (mean ± SD)

SST concentration (mol/L)	ODs	Inhibitory rates (%)
10-6	0.19 ± 0.03b	30.53
10-7	0.23 ± 0.02b	15.81
10-8	0.25 ± 0.03	7.77
10-9	0.26 ± 0.03	4.48
10-10	0.27 ± 0.04	0
0	0.27 ± 0.04	0

^bP < 0.01 vs control group.

Table 2 Effects of somatostatin on HSC apoptosis (mean ± SD)

Somatostatin concentration (mol/L)	Apoptosis rate (%)
10-6	16.54 ± 4.59b
10-7	6.06 ± 1.79b
10-8	2.81 ± 0.72
10-9	2.25 ± 0.98
10-10	1.55 ± 0.64
0	1.53 ± 1.19

^bP < 0.01 vs control group.